Insomnia is a common complaint many physicians hear, and its incidence has only increased since the global pandemic. Test your knowledge on insomnia and its treatment.
The U.S. Food and Drug Administration recently approved aducanumab, the first treatment that aims to slow the progression of Alzheimer’s disease. But approval of the drug has provoked mixed reactions from the scientific community.
